
Dr Lal Pathlabs Ltd
NSE: LALPATHLAB BSE: 539524
₹1405.80
(-0.84)%
Tue, 03 Feb 2026, 09:27 pm
Market Cap237.95B
PE Ratio44.47
Dividend0.88
dr lal pathlabs ltd History
1949
- Late Dr. Major S.K. Lal commenced the business of providing pathology services and maintaining a blood bank
1975
- Late Dr. Major S.K. Lal and (Hony.) Brig. Dr. Arvind Lal entered into a partnership under the name 'Central Clinical Laboratory'
1977
- Late Ms. Vimla Lal was inducted into the partnership with (Hony.) Brig. Dr. Arvind Lal
1995
- The Company was incorporated as Dr. Lal PathLabs Private Limited
2001
- Received the ISO 9001:2008 certification for the quality management system
2002
- Fully accredited by the College of American Pathologists' Laboratory Accreditation Program
2005
- Investment by WestBridge I Investments Holdings
2007
- Dr. Vandana Lal was inducted into the partnership by a deed of partnership
2008
- Awarded the CNBC TV18 Emerging India Award 2008 by ICICI Bank Business Banking
- Acquisition of Paliwal Medicare Private Limited and Paliwal Diagnostics Private Limited
2010
- Franchisor of the Year in healthcare, at the Franchise Plus Awards
- Honourable mention in the healthcare category at the Milagrow Trailblazers Brand Innovator Awards
- Establishment of the National Reference Laboratory
2012
- Diagnostic Service Provider Company of the Year, by Frost & Sullivan
- Named a Computerworld Honours Laureate by the Computerworld Honours Program
2013
- Best Diagnostic Company in India at the VC Circle Healthcare Summit
- Investment pursuant to purchase of shares by WestBridge Crossover Fund, LLC from WestBridge I Investment Holdings
- Investment by SIH
- Investment pursuant to purchase of shares by Wagner Limited from WestBridge I Investment Holdings
2014
- Acquisition of APL Clinical Institute of Clinical Laboratory & Research Private Limited
- Received the ISO 27001:2013 certification for the information management system
- Received an NABL certificate of accreditation under standard ISO 15189:2012 for Medical Laboratories
2015
- The Company was converted into a public company
- The name of the Company was changed to Dr. Lal PathLabs Limited
- Received the Data Quest Technology Award for Excellence in the implementation and use of technology for business benefits in the 'Cloud' category
- Received the certificate of affiliation from the Healthcare Sector Skill Council
- Amalgamation of Sanya Chemicals Private Limited, Amolak Diagnostics Private Limited, Medex Healthcare Private Limited, Medicave Diagnostic Centre Private Limited, Medicave Medical Systems Private Limited and the Company
2016
- Dr Lal PathLabs Presents First Trimester Screening Test for Screening Prenatal Disorders
- Dr Lal PathLabs Enhanced Liver Fibrosis Test For Mapping Liver Functionality
- Dr Lal PathLabs is the First Private Lab in India to Introduce Electron Microscopy
2017
- Dr Lal PathLabs is Amalgameted with Ria and Pathology Private Limited
2018
- Amalgamation of Shree Computerised Pathology Laboratory, Modern Diagnostics & Modern Lab
2021
- Dr Lal PathLabs Launches Bangalore Reference Laboratory.
2023
- NCLT has given approval for Amalgamation between Dr. Lal PathLabs Limited and APL Institute of Clinical Laboratory & Research Private Limited.
2024
- NCLT, Allahabad Bench sanctioned the Scheme of Amalgamation between two Subsidiary Companies of Dr. Lal PathLabs Limited.
Open Your Free Demat Account Now!
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800